Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Braidwell LP

Braidwell LP lessened its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.2% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 91,300 shares of the medical equipment provider’s stock after selling 9,200 shares during the quarter. Braidwell LP’s holdings in Intuitive Surgical were worth $44,853,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. FMR LLC grew its position in Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after acquiring an additional 838,793 shares in the last quarter. Fisher Asset Management LLC grew its position in Intuitive Surgical by 1.8% in the third quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock valued at $2,349,441,000 after acquiring an additional 86,208 shares in the last quarter. Baillie Gifford & Co. grew its position in Intuitive Surgical by 0.6% in the third quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock valued at $1,890,676,000 after acquiring an additional 24,183 shares in the last quarter. American Century Companies Inc. grew its position in Intuitive Surgical by 3.0% in the second quarter. American Century Companies Inc. now owns 2,398,193 shares of the medical equipment provider’s stock valued at $1,066,837,000 after acquiring an additional 70,556 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in Intuitive Surgical by 1.3% in the third quarter. Charles Schwab Investment Management Inc. now owns 2,227,467 shares of the medical equipment provider’s stock valued at $1,094,288,000 after acquiring an additional 28,703 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling

In other Intuitive Surgical news, CEO Gary S. Guthart sold 18,151 shares of the firm’s stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the sale, the chief executive officer now directly owns 24,219 shares in the company, valued at approximately $12,391,166.97. This trade represents a 42.84 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the sale, the chief financial officer now owns 8,757 shares of the company’s stock, valued at $4,746,819.42. The trade was a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 50,459 shares of company stock valued at $26,080,251 over the last three months. Company insiders own 0.90% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on ISRG shares. Royal Bank of Canada increased their target price on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. Evercore ISI reiterated a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Redburn Atlantic upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and increased their target price for the company from $380.00 to $510.00 in a research note on Friday, August 2nd. Robert W. Baird increased their target price on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. Finally, Stifel Nicolaus increased their target price on Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $526.06.

Intuitive Surgical Stock Performance

ISRG stock opened at $538.55 on Friday. The stock has a market capitalization of $191.82 billion, a price-to-earnings ratio of 86.58, a PEG ratio of 5.30 and a beta of 1.39. Intuitive Surgical, Inc. has a 1 year low of $304.50 and a 1 year high of $552.00. The stock’s fifty day moving average is $508.91 and its two-hundred day moving average is $467.29.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. As a group, analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.